Guest Host: Steve Roberts

A new study suggests antidepressants may be no more effective than placebo in all but severe cases of depression. A look at how drug effectiveness is measured and weighed against safety concerns in and beyond the drug approval process.

Guests

  • Dr. William Potter serves on the FDA's Psychopharmacologic Drugs Advisory Committee, vice president for translational neuroscience at Merck Research Laboratories; board-certified psychiatrist
  • Dr. Jerry Avorn Professor of Medicine at Harvard Medical School; Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital; author "Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs"
  • Blair Johnson professor of psychology, University of Connecticut; coauthor on new antidepressant study
  • Gardiner Harris science reporter for "The New York Times"

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, May 27 2016President Barack Obama makes a historic visit to Hiroshima. The Taliban choose a new leader after a U.S. drone strike kills Mullah Mansour. And a far right candidate in Austria narrowly loses the presidential election. A panel of journalists joins guest host Sabri Ben-Achour for analysis of the week's top international news stories.

Friday News Roundup – Domestic

Friday, May 27 2016Donald Trump now has enough delegates to clinch the Republican nomination, according to the Associated Press. A State Department review criticizes Hillary Clinton's use of a private email server. And 11 states sue the federal government over a transgender bathroom directive. A panel of journalists joins guest host Sabri Ben-Achour for analysis of the week's top national news stories